Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)

ClinicalTrials.gov ID: NCT03656692

Public ClinicalTrials.gov record NCT03656692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of Acthar Gel in Subjects With Severe Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis (NIPPU)

Study identification

NCT ID
NCT03656692
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Mallinckrodt
Industry
Enrollment
5 participants

Conditions and interventions

Interventions

  • Acthar Gel Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2018
Primary completion
Jul 13, 2020
Completion
Jul 13, 2020
Last update posted
Aug 2, 2021

2018 – 2020

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Blue Ocean Clinical Research Clearwater Florida 33761
Midwest Eye Institute Indianapolis Indiana 46290
Massachusetts Eye Research and Surgery Institution (MERSI) Waltham Massachusetts 02451
Metropolitan Eye Research and Surgery Institute Palisades Park New Jersey 07650
Bergstrom Eye Research, LLC Fargo North Dakota 58103
Valley Retina Institute, PA McAllen Texas 78503
Foresight Studies, LLC San Antonio Texas 78240
Virginia Eye Consultants Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03656692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03656692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →